Bill Snyder Archive — Page 112 of 118

February 11, 2013

VU, GlaxoSmithKline team to develop novel treatments for severe obesity

Vanderbilt University has signed a collaboration agreement with GlaxoSmithKline (GSK) for the discovery, development and commercialization of novel therapies for severe obesity.

By Bill Snyder
February 7, 2013

Humble yeast helps predict how genes are regulated

Budding yeast occupies a place of honor in the pantheon of human history. Saccharomyces cerevisiae has been used for baking and alcoholic fermentation for thousands of years.

By Bill Snyder
February 7, 2013

For people with ASD, adulthood no easy transition

One of the critical, unmet needs for people with autism spectrum disorder (ASD) is support for the transition into adulthood.

By Bill Snyder
January 31, 2013

Vanderbilt, GE unite to study colon tumor development

Vanderbilt University has partnered with GE Global Research in Niskayuna, N.Y., the technology development arm of the General Electric Company, to better define — at the cellular level — how colon tumors form and develop.

By Bill Snyder
January 31, 2013

ResearchMatch adds registry for autism disorders

ResearchMatch, a national on-line volunteer recruitment service hosted by Vanderbilt University, has launched a sub-registry for autism spectrum disorders (ASD) to increase the participation of children and adults with autism in clinical research studies.

By Bill Snyder
January 24, 2013

Pharmacology society honors Limbird’s impact

Vanderbilt University’s Lee Limbird, Ph.D., has received one of pharmacology’s highest honors — the 2013 Julius Axelrod Award from the American Society for Pharmacology and Experimental Therapeutics (ASPET).

By Bill Snyder